Zurich, Switzerland
10 February 2012
Since 2004, the SSCN organizes an annual one-day conference, during which the latest developments in stem cell research and its potential applications are discussed and an exchange between interested parties (researchers, clinicians, and especially students) is encouraged.
The Congress is divided into two keynote lectures by international experts, several talks by Swiss researchers and clinicians, as well as short presentations of selected registered participants on the basis of their submitted abstracts. In addition, a poster session will be held, which represents an ideal forum for lively discussions.
London, UK
16 February 2012
Continued improvement in the nation’s health depends upon the development of affordable and effective medicines and new therapeutic treatments. The last 20 years has seen the growth of a global healthcare industry based on human proteins produced in transformed mammalian cell lines, with a current market value of £30 billion/year. There is now an opportunity to replicate this growth in new industries using human stem cells in pharmaceutical and regenerative medicine applications. This meeting will focus on exploring the biological and engineering challenges which lie ahead before cell based therapies can become an everyday reality.
New York, USA
21 February 2012
Meet more than 30 of the world's leaders in this rapidly evolving industry, ask questions, and then end the day with a reception and networking.
In just one day, the Stem Cell Summit will bring the future of this dynamic industry to life for investors, industry, practitioners, and analysts.
Olympic Valley (Lake Tahoe), USA
11 - 16 March 2012
Stem cell studies have demonstrated unexpected plasticity of cellular differentiation programs and challenged the long-standing paradigm of progressive irreversibility of cell fate during development. The field of stem cell biology interfaces with many areas of basic biology including developmental biology, tissue growth and homeostasis, regeneration, cancer and aging. Unlike most meetings on stem cells, the Keystone Symposia meeting on The Life of a Stem Cell: From Birth to Death focuses on stem cells within the context of the organism. Stem cell systems are discussed with respect to the life cycle of whole organisms: gametogenesis and embryogenesis, where tissue types are established; maturity, where organ systems are maintained in homeostasis; and aging, where stem cells systems change physiologically or because of disease. Speakers have been chosen to broadly reflect lessons learned from a variety of model organisms, experimental approaches and organ systems.
Mandelieu, France
20 - 22 April 2012
The European School of Haematology (ESH) is a non-profit institution for continuing education founded in 1986, to promote and facilitate access to state of the art and cutting-edge knowledge in haematology and related disciplines, at the European level.
This workshop will cover Characterization of MSCS, Disease Models, Immunomodulation, Expansion of MSCS and Clinical Applications.
Sofia, Bulgaria
22 - 25 April 2012
The ESH-EBMT training course is now in its 16th year and as popular as ever. The chairs, Jane Apperley, Enric Carreras, Eliane Gluckman, and Tamas Masszi are developing the programme which will address such topics as the best donor/unit, current ethical issues in HSCT, cord blood or haploidentical.
Vatican City, Vatican City
25 - 28 April 2012
The 2012 Congress will have the same aim as the one of the previous ones: i.e. to take a view of the present and future clinical applications of stem cell research, with attention to the ethical aspects of these applications. However, recent moves of this research and new biological finding draws us to include in the program the developments of induced pluripotent stem cells (iPSCs) obtained by reprogramming ordinary, differentiated cells of the adult organism, such as skin cells (fibroblasts) (including the creation of cellular models of diseases, and possible developments in the field of regenerative medicine). During the meeting, we will follow the developments in the field of umbilical cord blood stem cells, and will pay attention to new sources of stem cells - stems cells from placenta, amniotic fluid and gingival fibroblasts. Finally, we will also consider other, more fundamental aspects of this research, which condition the success of treatments with "adult" stem cells, such as: understanding of pluripotency, research on stem cell maintenance, migration, differentiation, the niche, and the paracrine effect.
Edinburgh, UK
21 - 22 May 2012
A symposium to honour Sir Ian Wilmut and to mark the opening of the new Scottish Centre for Regenerative Medicine Building.
Speakers include: Shinya Yamanaka, Sir John Gurdon, Giulio Cossu, Austin Smith FRS, Alan Colman, Magdalena Götz, Timm Schroeder, Hans Clevers, Markus Grompen, Christine Mummery, Mick Bhatia, Lorenz Studer.
Lead sponsors: AstraZeneca and Life Technologies Corporation
Liverpool, UK
28 May - 3 June 2012
On behalf of the International HLA and Immunogenetics Workshop (IHIW); the European Federation for Immunogenetics (EFI) and the British Society for Histocompatability and Immunogenetics (BSHI) you are invited to attend the 16th International HLA and Immunogenetics Workshop and Joint Conference in Liverpool.
The Joint Conference programme will include plenary sessions focused on: immunogenetics of solid organ transplantation; immunogenetics of haematopoietic stem cell transplantation; anthropology; bioinformatics, new frontiers in immunogenetics; pharmacogenomics.
The Teaching Sessions will cover topics including histocompatibility and immunogenetics and issues associated with organ and haematopoietic progenitor cell transplantation.
Yokohama, Japan
13 - 16 June 2012
The ISSCR's annual meeting has become the world's premier stem cell research event. The meeting serves as the largest forum for stem cell and regenerative medicine professionals from around the world.
Through lectures, symposia, workshops, and events attendees will experience innovative stem cell and regenerative medicine research, advances and what's on the horizon.The meeting features more than 1,000 abstracts, nearly 150 speakers and provides numerous networking and professional development opportunities and social events.
Edinburgh, UK
28 - 29 June 2012
Determining the origin of tissue stem/progenitor cells is key to our understanding of developmental biology. This meeting will focus on how and when self-renewing tissue stem cells arise during embryonic development. Common features between different stem cell lineages will be discussed, and how modeling can inform in vivo studies.
Cambridge, UK
9 - 11 July 2012
The symposium aims to critical evaluate novel findings and models of how stem cells contribute to cancer and will cover the following themes: (1) Cells at the origin of cancer, (2) Stem cells and metastasis, (3) Cancer stem cell niches, and (4) Approaches to identify cancer stem cells.
The programme includes world-class experts in the field of stem cells and cancer from Europe and the United States. To give new junior investigators as well as postodcs and PhD students the opportunity to discuss their work with established scientists, every session will have at least one selected speaker from the submitted posters.
Heidelberg, Germany
29 August - 1 September 2012
This conference will describe the role of stem cells in normal and diseased physiology, as well as the ways in which stem cells can be used for curative ends. The overall aim is to integrate basic, translational and clinical aspects of stem cell research into a single framework.
The goal is to give participants an overview of the model systems, and of the scientific and logistical framework involved in gaining and exploiting basic knowlege of stem cell biology in cancer research and regenerative medicine settings.
Topics: pluripotency, tissue stem cells, stem cell specification and transdifferentiation, niche, signaling and metabolism; cancer stem cells, tissue repair and regeneration, disease modeling and drug discovery.
Vienna, Austria
5 - 8 September 2012
The mission of TERMIS (Tissue Engineering and Regenerative Medicine International Society) is to bring together the international community of persons interested in the field of tissue engineering and regenerative medicine research.
The TERMIS World Congress is the premier location for the international community of TERMIS members to present their research and interact with top researchers, clinicians, scientists, students and industry.
The major goals of the meeting are: to discuss the translational aspects of tissue engineering and regenerative medicine; to promote young researchers; to connect with other societies concerning important aspects of tissue regeneration; to provide a platform for fruitful exchange between industry and academics.
Boston, USA
18 - 20 September 2012
The World Cord Blood Congress is where science and business come together to advance the cord blood banking and therapeutics sectors.
Speakers include senior-level executives from private and public cord blood banks, hospitals, biotech companies, academia, and government.